MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Moexipril Hydrochloride And Hydrochlorothiazide, and what generic alternatives are available?
Moexipril Hydrochloride And Hydrochlorothiazide is a drug marketed by Chartwell Rx, Glenmark Pharms, Heritage Pharms, and Teva. and is included in four NDAs.
The generic ingredient in MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; moexipril hydrochloride. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; moexipril hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE?
- What are the global sales for MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE?
- What is Average Wholesale Price for MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE?
Summary for MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Clinical Trials: | 3 |
Patent Applications: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE at DailyMed |
![MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE drug patent expirations Drug patent expirations by year for MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE](/p/graph/s/t/MOEXIPRIL_HYDROCHLORIDE_AND_HYDROCHLOROTHIAZIDE-patent-expirations.png)
Recent Clinical Trials for MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Teva Pharmaceuticals USA | Phase 1 |
Paddock Laboratories, Inc. | Phase 1 |
See all MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE clinical trials